Date Initiated by Firm |
August 06, 2014 |
Date Posted |
September 19, 2014 |
Recall Status1 |
Terminated 3 on April 14, 2017 |
Recall Number |
Z-2671-2014 |
Recall Event ID |
68974 |
PMA Number |
P010021S024 |
Product Classification |
Assay,enzyme linked immunosorbent,hepatitis c virus - Product Code MZO
|
Product |
VITROS Immunodiagnostic Products Anti-HCV Reagent Pack for in vitro qualitative detection of immunoglobulin G antibody to hepatitis C virus (anti-HCV) in human serum and plasma. REF 680 2454, IVD -- Ortho-Clinical Diagnostics High Wycombe UK. Note that one sales unit has 5 Reagent Packs contained within it. Each Reagent Pack can test for 100 samples (patient, Quality Control, etc.). |
Code Information |
Lot 9090 (exp. December 15, 2014) |
Recalling Firm/ Manufacturer |
ORTHO-CLINICAL DIAGNOSTICS FELINDRE MEADOWS Bridgend United Kingdom
|
For Additional Information Contact |
Jennifer Paine 908-218-8776
|
Manufacturer Reason for Recall |
VITROS Immunodiagnostic Products Anti-HCV kit lot 9090 has been observed producing sporadic lower than expected VITROS Anti-HCV test results due to an approximate signal loss of up to 66.2% which can result in unexpected negative test results being obtained for reactive sample fluids (quality control and patient samples).
|
FDA Determined Cause 2 |
Packaging process control |
Action |
All US consignees (users) who were shipped the affected lot VITROS HCV Reagent Pack were sent communications via FedEx and/or US Priority Mail (PO Boxes only) on 8/06/14, and advised of the issue and to immediately discontinue using all remaining inventory of VITROS Anti-HCV Reagent Packs Lot 9090. For additional information, please contact OCD's Customer Technical Service representatives at 1-800-421-3311. |
Quantity in Commerce |
463 sales units |
Distribution |
NY, NJ, CT, MA, PA, VA, MD, FL and GA |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
PMA Database |
PMAs with Product Code = MZO and Original Applicant = Ortho-Clinical Diagnostics, Inc.
|